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Abstract
Background: Lactation increases energy demands four- to five-fold, leading to a two- to three-fold increase in
food consumption, requiring a proportional adjustment in the ability of the lactating dam to absorb nutrients and
to synthesize critical biomolecules, such as cholesterol, to meet the dietary needs of both the offspring and the
dam. The size and hydrophobicity of the bile acid pool increases during lactation, implying an increased
absorption and disposition of lipids, sterols, nutrients, and xenobiotics. In order to investigate changes at the
transcriptomics level, we utilized an exon array and calculated expression levels to investigate changes in gene
expression in the liver, duodenum, jejunum, and ileum of lactating dams when compared against age-matched
virgin controls.
Results: A two-way mixed models ANOVA was applied to detect differentially expressed genes. Significance calls
were defined as a p < 0.05 for the overall physiologic state effect (lactation vs. control), and a within tissue
pairwise comparison of p < 0.01. The proportion of false positives, an estimate of the ratio of false positives in the
list of differentially expressed genes, was calculated for each tissue. The number of differentially expressed genes
was 420 in the liver, 337 in the duodenum, 402 in the jejunum, and 523 in the ileum. The list of differentially
expressed genes was in turn analyzed by Ingenuity Pathways Analysis (IPA) to detect biological pathways that were
overrepresented. In all tissues, sterol regulatory element binding protein (Srebp)-regulated genes involved in
cholesterol synthesis showed increased mRNA expression, with the fewest changes detected in the jejunum. We
detected increased Scap mRNA in the liver only, suggesting an explanation for the difference in response to
lactation between the liver and small intestine. Expression of Cyp7a1, which catalyzes the rate limiting step in the
bile acid biosynthetic pathway, was also significantly increased in liver. In addition, decreased levels of mRNA
associated with T-cell signaling were found in the jejunum and ileum. Several members of the Solute Carrier (SLC)
and Adenosine Triphosphate Binding Cassette (ABC) superfamilies of membrane transporters were found to be
differentially expressed; these genes may play a role in differences in nutrient and xenobiotic absorption and
disposition. mRNA expression of SLC39a4_predicted, a zinc transporter, was increased in all tissues, suggesting that
it is involved in increased zinc uptake during lactation. Microarray data are available through GEO under GSE19175.
Conclusions: We detected differential expression of mRNA from several pathways in lactating dams, including
upregulation of the cholesterol biosynthetic pathway in liver and intestine, consistent with Srebp activation.
Differential T-Cell signaling in the two most distal regions of the small intestine (ileum and jejunum) was also
noted, as well as differential expression of transporters that likely play a key role in nutrient uptake.
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Lactation is a time of a four- to five-fold increased
energy demand imposed by the suckling young that
requires a proportional adjustment in the ability of the
lactating dam to absorb nutrients and to synthesize criti-
cal biomolecules to meet the dietary needs of both the
offspring and the dam [1-3]. Lactating rats have a two-
to three-fold increase in food consumption (hyperpha-
gia) [1-3], in part through the decreased suppression of
appetite accompanying decreased serum leptin [4].
Diet and hyperphagia have been shown to influence
the rate of cholesterol synthesis, which is increased in
the liver and small intestine in the lactating rat [5,6]. Of
these tissues, the liver is the primary contributor to
serum levels of cholesterol, and shows a quantitatively
greater increase in the rate of cholesterol synthesis dur-
ing lactation [5]. 3-Hydroxy-3-methylglutaryl-coenzyme
A reductase (Hmgcr), the enzyme catalyzing the rate-
limiting step of cholesterol synthesis, shows significantly
increased activity in the liver during lactation compared
to virgin and nonlactating control rats [7,8]. Cholesterol
synthetic and lipogenic genes are regulated by transcrip-
tion factors termed sterol regulatory element binding
proteins (Srebp); the activity of Srebp proteins is in turn
regulated by the Srebf chaperone (Scap) and the Insulin
induced genes (Insig).
Circulating serum levels of several hormones that reg-
ulate metabolism are decreased during lactation in the
rat, including thyroid hormone, insulin and leptin [4].
Such changes in hormone signaling and diet are likely
to have large influences on the activation of their corre-
sponding pathways. Receptors for leptin, thyroid
hormone, and insulin are expressed in both the liver
and small intestine [9-14], with liver being considered a
major site of insulin signaling [9] and thyroid receptor b
(TRB, Thrb) being the dominant form of the thyroid
receptor in both tissues [14]. Leptin acts on the small
intestine and inhibits sugar uptake [11], and the liver is
a major source of the soluble form of the leptin recep-
tor, particularly under conditions of negative energy bal-
ance [12], as occurs in lactation [1]. Therefore, altered
serum levels of these hormones would be expected to
influence mRNA expression of downstream genes.
Our laboratory has been investigating the effects of
lactation on the synthesis and transport of bile acids in
the liver and small intestine in the rat [15]. Bile acids
are synthesized in the liver from cholesterol, and are
essential for the biliary excretion of cholesterol and for
the efficient intestinal absorption of cholesterol, lipid-
soluble vitamins and lipids [16]. Bile acids are secreted
into bile by the Bile salt export pump (Bsep; Abcb11),
taken up across the apical membrane of the enterocyte
in the terminal ileum by the Apical sodium-dependent
bile acid transporter (Asbt; Slc10a2), effluxed into portal
blood by the Organic solute transporter heterodimer
(Osta/b), and then taken up in the hepatocyte by the
Sodium-dependent taurocholate co-transporting poly-
peptide (Ntcp; Slc10a1) [17]. Expression of Ntcp, Bsep
and Asbt are all increased in lactation [18,19], as is the
size of the bile acid pool [15]. We recently demonstrated
that expression and activity of Cyp7a1, the enzyme
catalyzing the rate limiting step in the conversion of
cholesterol to bile acids, is increased at mid-lactation
(day 10 - 14 postpartum) [15]. Further, this increase
occurs at 16 h (10 h of light on a 12 h/light dark cycle;
4 PM) and represents a shift in the diurnal rhythm of
Cyp7a1 expression, which is normally maximal in the
dark cycle (i.e., 22 h). Increased expression of Cyp7a1 is
apparently due to decreased expression of Fibroblast
Growth Factor 15 (Fgf15) in the ileum, resulting in
decreased Fgf15 signaling via Fibroblast Growth Factor
Receptor 4 (Fgfr4) and Erk1/2 in liver and decreased
repression of Cyp7a1 transcription [20].
In order to identify further changes in expression of
genes important in the regulation of bile acid and cho-
lesterol synthesis, as well as other genes important in
meeting nutritional demands and physiological changes
of the lactating rat, we carried out a microarray experi-
ment in the liver and small intestine of the lactating
dam at 16 h on days 10 -11 postpartum and compared
these to gene expression in female virgin control rats.
Results
Detection of differentially expressed genes
A repeated measures mixed model ANOVA was used to
test for effects of tissue and lactation, as described in
Methods. A statistically significant difference was deter-
mined to exist when the physiologic state effect (com-
parison between all control samples against all lactating
samples) yielded a p < 0.05 and the effect of lactation
within a given tissue (physiologic state simple effect)
yielded a p < 0.01. Analyzed data are available in Addi-
tional File 1: Statistical_Analysis_and_Statistical_Pat-
tern_Matching_Results.txt. These p-values were used as
cutoffs for differentially expressed genes and led to the
proportions of false positives that are listed in the sec-
tion titled “Approximation of false discoveries” below.
A number (1,114) of genes demonstrated an interac-
tion at p < 0.01 and 556 genes passed a Benjamini-
Hochberg false discovery rate correction at FDR = 0.05
(Additional File 2: Benjamini_Hochberg_False_Discov-
ery_Rates.txt). These genes represent those that dis-
played a different response to lactation in one tissue
with respect to the other tissues. However, it should be
noted that this list was not a useful cutoff, as genes that
responded uniformly to lactation across all tissues
would be ignored. Also, five genes that passed the
Benjamini-Hochberg correction did not show any significant
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within each tissue. Since the primary purpose of this study
was to characterize the influence of lactation on gene
expression on these tissues, the interaction term was not
used. The tissue effect p-values indicated that many (70% at
p < 0.01) genes were differentially expressed across tissues,
due to the large difference in cell types between the liver
and the small intestine. Therefore, we chose the cutoffs of a
physiologic state main effect at p < 0.05 and the effect of lac-
tation within at least one tissue at p < 0.01, as described in
the Methods.
Although not as many genes were detected as signifi-
cantly differentially expressed compared to the overall
tissue effect, the overall physiologic state effect and the
pairwise comparisons (effect of lactation in each tissue)
showed a high number of low p-values, indicating that
the tissues in question responded to lactation at the
l e v e lo fm R N A .S e v e r a lg e n e sw e r ed o w n r e g u l a t e di n
the duodenum only (34 genes), with 23 genes showing
over a 50% decrease. Members of this group are listed
as pattern “-100” in Additional File 1. Histograms dis-
playing the distribution of p-values are in Additional
File 3: Histograms_of_p_values.ppt , and volcano plots
displaying each tissue’s response to lactation are in
Additional File 4: Volcano_plots.doc.
Approximation of false discoveries
The proportion of false positives is an approximation of
the ratio of false positives in the list of genes listed as dif-
ferentially expressed. An estimate of the number of false
positives was calculated for all tissues using genes where
p < 0.05 for an overall physiologic state effect, and for
each tissue using genes with an effect of lactation within
each tissue (here defined as a simple effect) of p < 0.01.
Thus, the proportion of false positives (PFP) was calcu-
lated as (p-value cutoff × number of genes tested)/num-
ber of genes detected below the p-value cutoff. The PFP
as defined by Fernando et al [21], is E(V)/E(R) where E
(V) is the expected number of false rejections of the null
hypothesis and E(R) is the expected number of rejections
of the null hypothesis. Here we utilized the actual num-
ber of rejections of the null hypothesis as the expected
value. Of all of the genes on the chip, 14,129 genes were
found to be annotated and expressed in at least one tis-
sue/physiologic-state combination and were used for sta-
tistical tests. Of those genes, 1,924 had an overall
physiologic state p-value of less than 0.05, yielding a PFP
of 0.37; at an overall physiologic state p < 0.01, 690 genes
were detected, yielding a PFP of 0.20. PFPs for the indivi-
d u a lt i s s u e sa tac u t o f fo fp<0 . 0 1f o rt h ep a i r w i s ec o m -
parisons (simple effects) were 0.17 for the liver, 0.28 for
the duodenum, 0.22 for the jejunum, and 0.18 for the
ileum. The PFPs for the individual tissue calculations
examined only the genes detected at a simple effect p <
0.01, and not at the combined overall physiologic state
cutoff of p < 0.05 together with the within-tissue cutoff
of p < 0.01, as some genes passed the p < 0.01 cutoff
within a given tissue, but did not pass the initial overall
physiologic state effect cutoff of p < 0.05. The rationale
for not utilizing the overall physiologic state effect
together with the within tissue physiologic state effect in
the calculation was that these multiple tests were utilized
for the same gene. Consequently, the list of genes
reported at both p < 0.05 for the physiologic state and p
< 0.01 for the comparison within a tissue was a subset of
the list of genes that only show a p < 0.01 within a tissue.
The physiologic state cutoff of p < 0.05 was chosen to
protect against repeated testing for each tissue; this value
was also chosen because changes that only occurred
within one tissue would be difficult to detect if the overall
physiologic state cutoff was made at p < 0.01. Approxi-
mations of the proportion of false positives in this range
(0.17 - 0.28) have been reported previously [22].
RT-PCR Validation of Microarray Data
Results from RT-PCR analyses agreed with the trends
detected in the microarray analyses (Table 1). In some
cases, significance calls differed, but the directionality of
the changes observed was consistent with the microar-
ray data. Possible causes for disagreement included the
fact that different methods of normalization were used
between RT-PCR and the microarray.
Patterns
Patterns were identified using statistical pattern matching
[23,24] by assigning each gene as significantly “up”,
“down”,o r“no change” detected in each tissue. The results
of the statistical pattern matching showed that fifteen
genes were upregulated in all four tissues, while thirty-one
genes were downregulated in all four tissues. Seventy-two
genes were upregulated in liver only, and another ninety-
nine genes were downregulated in liver only. Results from
analyses of each pattern using DAVID [25] are shown in
additional file 5: DAVID_output_file.txt.
Of the fifteen genes upregulated in every tissue (Table 2),
seven were identified by DAVID as being involved in
the Biosynthesis of Sterols pathway, where p = 4.59 ×
10
-13, using the list of “Up in All Tissues” for the
DAVID analysis. One gene, transmembrane protein 97
(Tmem97) ,h a sb e e ni d e n t i f i e da sb e i n gr e g u l a t e db y
the Srebp proteins [26,27], and was recently suggested
to aid in Low density lipoprotein receptor (Ldlr) func-
tion [26]. Another gene, RNA (guanine 9) methyltrans-
ferase domain containing 2 (Rg9mtd2), is the homolog
for a tRNA methyl transferase that occurs in yeast
[28]. Slc39a4_predicted was upregulated in all tissues,
consistent with increased zinc absorption during lacta-
tion, and is discussed further below.
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all tissues (Additional File 6: Genes_with_decreased_
mrna_all_tissues.doc). According to the over-representa-
tion analysis in DAVID, the KEGG T cell receptor pathway
was over-represented in this group (p = 0.004) [29,30]
(Additional File 5), although only three genes appeared in
this list. This pathway did not pass any of the multiple
testing procedures available in DAVID, but is consistent
with the IPA results, which flagged “T-cell signaling and
differentiation” to be downregulated in the jejunum and
ileum (Figure 1).
Genes downregulated only in the duodenum were also
investigated using DAVID, as several genes revealed a
strong downregulation in this tissue (Additional File 5).
Many of these genes have been identified as being
expressed in the pancreas, i.e., eight of the 34 genes in
this group matched the Sp_PIR keyword “pancreas” (p =
5.00 × 10
-15). The function of these genes in the
Table 1 RT-PCR validation of selected genes from the microarray
RT-PCR
Measurements
Transcript
Cluster ID RL RD RJ RIL
Tmem97 7080099 1.52
(p = 0.021)
2.60
(p < 0.01)
1.59
(p = 0.42)
1.73
(p = 0.072)
Npc1l1 - 1.00
(p = 1.00)
1.27
(p = 0.49)
1.22
(p = 0.16)
0.88
(p = 0.72)
Abcb1a 7250393 0.82
(p = 0.91)
0.83
(p = 0.77)
0.72
(p = 0.09)
0.65
(p < 0.01)
Cyp1a1 7336681 2.98
(p = 0.93)
1.12
(p = 0.64)
2.06
(p < 0.01)
0.78
(p = 0.89)
Cyp3a23/3a1 7100149 1.83
(p = 0.12)
1.30
(p = 1.00)
BDL BDL
Fdft1 7139070 1.36
(p = 0.11)
2.58
(p = 0.22)
1.02
(p = 0.99)
2.41
(p = 0.018)
Hmgcr 7202670 2.05
(p < 0.01)
1.52
(p = 0.30)
1.14
(p = 0.80)
1.18
(p = 0.48)
Slc39a4 7329323 2.71
(p = 0.59)
2.92
(p < 0.01)
2.20
(p < 0.01)
1.99
(p < 0.01)
Sqle 7317317 1.80
(p < 0.01)
2.66
(p = 0.034)
1.71
(p = 0.50)
1.59
(p = 0.056)
Ugt2b36 (Ugt2b4) 7117373 0.85
(p = 0.047)
0.76
(=0.41)
0.39
(p = 0.21)
0.62
(p = 1.00)
Microarray
Mean Log2
Measurements RL RD RJ RIL
Tmem97 7080099 1.92
(p < 0.01)
2.03
(p < 0.01)
1.82
(p < 0.01)
2.15
(p < 0.01)
Abcb1a 7250393 0.63
(p < 0.01)
0.66
(p < 0.01)
0.65
(p < 0.01)
0.70
(p = 0.01)
Cyp1a1 7336681 2.29
(p < 0.01)
1.23
(p = 0.35)
1.71
(p = 0.02)
0.67
(p = 0.03)
Cyp3a23/3a1 7100149 1.69
(p < 0.01)
0.98
(p = 0.81)
1.05
(p = 0.50)
1.04
(p = 0.58)
Fdft1 7139070 1.38
(p < 0.01)
1.98
(p < 0.01)
1.42
(p < 0.01)
1.55
(p < 0.01)
Hmgcr 7202670 1.97
(p < 0.01)
1.64
(p < 0.01)
1.17
(p = 0.14)
1.38
(p < 0.01)
Slc39a4 7329323 2.81
(p < 0.01)
1.89
(p < 0.01)
1.65
(p < 0.01)
1.68
(p < 0.01)
Sqle 7317317 1.83
(p < 0.01)
2.27
(p < 0.01)
1.72
(p < 0.01)
1.70
(p < 0.01)
Ugt2b36 (Ugt2b4) 7117373 0.96
(p = 0.86)
0.57
(p < 0.01)
0.37
(p < 0.01)
1.00
(p = 0.97)
Ratios were calculated as Lactating measurement divided by Control measurement. RT-PCR data is reported as the ratio of normalized measurements, and
microarray data is reported as the ratio of normalized, untransformed intensities. p-Values were calculated using a mixed models approach as described in
methods. RL, RD, RJ and RIL are the Ratio of Lactation to Control in liver (L), duodenum (D), jejunum (J), and ileum (IL), respectively. BDL, below detection limit.
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lactation is not known.
The list of genes upregulated in all parts of the small
intestine was not significantly enriched by any KEGG
pathways in DAVID. The term Lipid Biosynthetic Pro-
cess was overrepresented (p = 0.001), although this term
did not pass any multiple testing correction available in
DAVID.
“The Fibronectin Type III fold” Interpro entry was
flagged as overrepresented in the list of genes downre-
gulated in the small intestine, but not in liver [Interleu-
kin receptor 22, alpha 2 (Il22ra2), Immunoglobulin
superfamily 9 (Igsf9), Insulin receptor (Insr), Rims bind-
ing protein 2 (Rimbp2),a n dProtein tyrosine phosphate
receptor type g (Ptprg)]. However, the relevance of the
downregulation of these genes in lactation is not known.
Categories overexpressed in the list of genes upregu-
lated in the liver only included the gene ontologies for
“response to nutrient levels” and “cholesterol metabolic
process”. The list of genes downregulated in the liver
showed the gene ontology associated with positive regu-
lation of programmed cell death and may partially
explain the increased liver size during lactation [31,32].
Bile acid biosynthesis
Expression of Cyp7a1, the enzyme catalyzing the rate
limiting step of bile acid biosynthesis, was detected to
be increased (p = 0.0002) in the liver with a 1.76-fold
change. Few other changes were detected in the bile
acid biosynthetic pathway. Expression of Cyp46a1,
Ch25h, Cyp27a1, Cyp39a1, Cyp7b1, Cyp8b1, Akr1d1,
Slc27a5, Acox2, Scp2,a n dBaat [33] did not show a sig-
nificant change in the liver, suggesting that the increase
in bile acid biosynthesis observed was triggered by the
increase in Cyp7a1 mRNA [15]. These data are consis-
tent with our earlier detailed characterization of mRNA
and protein expression of Cyp7a1, Cyp27a1 and Cyp8b1
in lactation [15].
Table 2 Genes that displayed increased mRNA during lactation in all tissues
Transcript
Cluster ID Gene Name
RL RD RJ RIL
7027017 Acetyl-Coenzyme A acetyltransferase 1.98
(p = 0.0173)
2.40
(p = 0.0049)
1.80
(p = 0.0363)
2.19
(p = 0.0128)
7080099 Transmembrane protein 96 1.92
(p = 0.0001)
2.03
(p = 2.8e-05)
1.82
(p = 0.0002)
2.15
(p = 8.7e-06)
7113785 Hydroxysteroid(17-beta) dehydrogenase 7 1.71
(p = 2.1e-06)
1.54
(p = 4.7e-05)
1.19
(p = 0.045)
1.51
(p = 0.0001)
7132836 PDZ binding kinase predicted* 1.56
(p = 0.0222)
1.88
(p = 0.0031)
1.66
(p = 0.0054)
1.54
(p = 0.0227)
7139070 Farnesyl diphosphate farnesyl transferase 1.38
(p = 0.0009)
1.98
(p = 4.7e-08)
1.42
(p = 0.0004)
1.55
(p = 4.1e-05)
7144691 Sterol-C4-methyl oxidase-like 1.41
(p = 0.0015)
2.19
(p = 1.9e-07)
1.45
(p = 0.0008)
1.80
(p = 8.2e-06)
7166170 Isopentenyl-diphosphate delta isomerase 1.61
(p = 0.0006)
2.11
(p = 2.8e-06)
1.33
(p = 0.0226)
1.91
(p = 2.6e-05)
7169182 Kinesin family member 20a_predicted* 1.46
(p = 0.0012)
1.50
(p = 0.0010)
1.33
(p = 0.0104)
1.45
(p = 0.0013)
7186293 Mevalonate (diphospho) decarboxylate 2.65
(p = 3.8e-05)
2.15
(p = 0.0004)
1.49
(p = 0.0316)
1.73
(p = 0.0042)
7199743 RNA (guanine-9-) methyltransferase domain containing 2 1.18
(p = 0.009)
1.42
(p = 3.6e-06)
1.19
(p = 0.0066)
1.30
(p = 0.002)
7250653 CYP51 1.24
(p = 0.0116)
2.14
(p = 1.8e-09)
1.50
(p = 4.2e-05)
1.89
(p = 6.7e-08)
7280610 UDP-Galactose-4-epimerase 1.65
(p = 0.0006)
1.50
(p = 0.0042)
1.36
(p = 0.0243)
1.53
(p = 0.0023)
7291805 Dehydrodolichyl diphosphate synthase 1.37
(p = 0.0003)
1.36
(p = 0.0005)
1.27
(p = 0.0041)
1.17
(p = 0.0447)
7317317 Squalene epoxidase 1.83
(p = 2.4e-05)
2.27
(p = 5.6e-07)
1.72
(p = 0.0001)
1.70
(p = 0002)
7329323 Solute carrier 39 (zinc transporter) member 4 2.81
(p = 2.5e-10)
1.89
(p = 9.9e-08)
1.65
(p = 2.1e-06)
1.68
(p = 1.2e-06)
To be considered part of a grouping, genes must have had a physiologic state p < 0.05 and at least one tissue simple effect p < 0.01. Reported p-values are the
tissue simple effect p-values. The tissue simple effect p-value represents the comparison between Lactation and Control in the corresponding tissue. For the
purposes of assigning patterns, the significance cutoff for the remaining tissues’ simple effect p-values was set to p < 0.05. Abbreviations used as in Table 1.
*Gene is at the Extended confidence level.
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Ileum 
Figure 1 T-cell signaling in lactating jejunum and ileum. Downregulation of T-cell signaling in the jejunum (top, p = 1.68 × 10
-7) and ileum
(bottom, p = 4.7 × 10
-4). Green shading indicates downregulation of the corresponding gene during lactation.
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The lists of differentially expressed genes for each tissue,
based on the overall physiologic state effect p-value and
the respective simple effects were examined by IPA. The
three overrepresented pathways with the lowest p-values
in each tissue are shown in Table 3, and selected path-
ways are discussed below.
Cholesterol synthesis and metabolism
“Biosynthesis of steroids” had the lowest p-value among
IPA’s “Canonical Pathways” in three of the four tissues,
with the jejunum being the exception. At the designated
cutoff (p < 0.01), the jejunum showed a much more
modest change in the “biosynthesis of steroids” pathway
(p = 0.011 for overrepresentation in jejunum; p < 1 ×
10
-6 in all other tissues). Detailed visualization of the
pathway revealed that the upregulated sections of the
“biosynthesis of steroids” pathway corresponded with
cholesterol synthesis (Additional Files 7, 8, 9, 10:
Biosynthesis_of_sterols_in_liver.jpg, Biosynthesis_of_ster-
ols_in_duodenum.jpg, Biosynthesis_of_sterols_in_jeju-
num.jpg, and Biosynthesis_of_sterols_in_ileum.jpg).
Since cholesterol synthesis is regulated by Srebp pro-
teins, Srebp-regulated genes were investigated further.
To determine if an exceptionally large number of Srebp-
regulated genes were in the list of differentially
expressed genes, a list of genes shown to be regulated
by Srebp by detection through microarray analysis in
Srebp-overexpressing and Scap knockout mice was used
for a right-tailed Fisher’s Exact test [34] using an online
calculator (http://www.langsrud.com/fisher.htm). Here, a
p-value of <0.01 in the tissue being tested was defined
as a positive test for the purpose of determining whether
a given gene was differentially expressed.
Of the 33 genes reported to be regulated by nuclear
Srebp proteins [34], 29 were present in the data set.
AF i s h e r ’s exact test p-value of p < 0.001 was calculated
for each tissue, with the jejunum (p = 0.00029) having
Table 3 Top three pathways for overrepresentation in each tissue
Liver
Pathway Fisher’s Exact test
p-value
BH
p-value
Members
Biosynthesis of steroids 3.50E-07 5.80E-05 ↑Dhcr7, ↑Fdft1,↑Hmgcr,↑Idi1, ↑Lss, ↑Mvd, ↑Sqle
LXR/RXR Activation 1.57E-04 1.30E-02 ↓Abcg5, ↓Abcg8, ↑Acaca, ↑Cyp7a1, ↓Hadh, ↑Hmgcr, ↓Lcat
Pentose/Phosphate Pathway 3.01E-04 1.67E-02 ↑Aldoc, ↑G6pd, ↑Gpi, ↓H6pd, ↓Pgm5
Duodenum
Pathway
Biosynthesis of steroids 1.13E-10 1.74E-08 ↑Dhcr7, ↑Fdft1, ↑Fntb, ↑Hmgcr, ↑Idi1, ↑Lss, ↑Mvd, ↑Sc5dl, ↑Sqle
Androgen and estrogen
metabolism
1.35E-04 1.04E-02 ↑Ftsj1, ↑Hsd11b1, ↑Hsd17b7, ↑Nsdhl, ↓Srd5a2, ↓Ugt2b7
Glycerolipid metabolism 1.46E-03 7.50E-02 ↓Cel, ↓Clps, ↓Glb1l2, ↓Pnlip, ↓Pnliprp1, ↓Pnliprp2
Jejunum
Pathway
T-Cell receptor signaling 1.68E-07 2.78E-05 ↓Bmx, ↓Cd8b, ↓Grap2, ↓Itk, ↓Malt1, ↓Pik3cg, ↓Pik3r1, ↓Ppp3cc, ↓Prkcq, ↓Ptprc,
↓Rasgrp1, ↓Trb
CD28 signaling in T helper
cells
1.17E-05 6.74E-04 ↓Grap2, ↓Itk, ↓Malt1, ↑Mapk9, ↓Pik3cg, ↓Pik3r1, ↓Ppp3cc, ↓Prkcq, ↓Ptprc, ↓Trb
TR/RXR activation 1.23E-05 6.74E-04 ↑Fga, ↑Gh1, ↓Klf9, ↑Ldlr, ↓Pik3cg, ↓Pik3r1, ↓Thra, ↓Thrb, ↓Thrsp
Ileum
Pathway
Biosynthesis of steroids 9.42E-08 1.71E-05 ↑Cyp24a1, ↑Dhcr7, ↑Fdft1, ↑Hmgcr, ↑Idi1, ↑Mvd, ↑Sc5dl, ↑Sqle
TR/RXR activation 3.16E-07 2.86E-05 ↑Fga, ↑Gh1, ↓Klf9, ↑Me1, ↓Nfcor2, ↓Pck1, ↓Pik3c2b, ↓Pik3cg, ↓Pik3r5,
↓Ppargc1a, ↓Thra, ↓Thrb
Thrombopoietin signaling 4.85E-05 2.53E-03 ↓Irs2, ↓Pik3c2b, ↓Pik3cg, ↓Pik3r5, ↓Plcg1, ↓Plcg2, ↓Prkce, ↓Prkcq
The pathways with the three lowest p-values from Fisher’s exact test for pathways from IPA’s “Canonical Pathways” database for each tissue are reported here
along with the corresponding p-value from a right-tailed Fisher’s exact test, the Benjamini-Hochberg (BH) adjusted p-value, and the genes within the pathway
that showed differential expression within the respective tissue (Members). Arrows in the Members column indicate the direction of change in lactating animals
relative to controls.
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genes). Additional File 11: Genes_Regulated_by_Srebp_
proteins.doc lists members of the cholesterol biosyn-
thetic pathway and other genes that have been shown to
be differentially expressed in Srebp-overexpressing mice
and Scap knockout mice [34] and indicates the p-values
f o re a c ht i s s u ea n dt h er a t i oo ft h eb a c k g r o u n d - c o r -
rected, normalized, untransformed intensities (lactation
intensity/control intensity). As shown in Figure 2,
Hmgcr mRNA expression was increased in three of the
four tissues, with no change detected in the jejunum
(p = 0.14). mRNA expression for the genes (Srebf1,
Srebf2)e n c o d i n gt h eS r e b pp r o t e i n sw e r en o td i f f e r e n -
tially expressed, although a tendency for a change was
detected in the jejunum, where the simple effect
comparison p-value for Srebf1 was 0.0006, and the over-
all physiologic state effect p value was 0.054. Expression
of Insig1 mRNA, which is regulated by Srebp activity,
showed a significant increase in each part of the small
intestine. In contrast, an increase in Scap mRNA
occurred in the liver only (p = 2.18E-7). Ldlr mRNA
was upregulated in the duodenum and jejunum, and
Tmem97 mRNA, an Srebp target [26], was upregulated
in all tissues; both Ldlr and Tmem97 proteins aid in
LDL uptake by cells [26].
Cholesterol uptake
The only gene known to mediate cholesterol uptake in
the gut, Npc1l1 [35], is not contained in the extended
dataset for the Affymetrix Rat Exon 1.0ST. Investigation
Figure 2 Plot of Mean Intensities for Known Cholesterol Biosynthetic Enzymes. The mean untransformed intensities were plotted against
tissue/physiologic state combination. C and L indicate the mean of Control and Lactating samples, respectively, within each tissue. Abbreviations
for genes are as follows. Dhcr7: 7-dehydrocholesterol reductase; Fdft1: farnesyl-diphosphate farnesyltransferase 1; Sc4mol: sterol-C4-methyl
oxidase-like; Idi1: isopentenyl-diphosphate delta isomerase 1; Mvd: mevalonate (diphospho) decarboxylase; Hmgcs: 3-hydroxy-3-methylglutaryl-
Coenzyme A synthase 1; Hmgcr: HMG Coenzyme A reductase; Lss: lanosterol synthase; Cyp51: cytochrome P450 family 51; Sqle: Squalene
Epoxidase. A red line between Control and Lactating symbols for a given gene indicates p > .0.01 for the tissue pairwise comparison within the
tissue from the mixed models repeated measures ANOVA on the log2 transformed intensities; the change was not considered significant for the
purposes of determining a list of differentially expressed genes. A black line between C and L symbols indicates p < 0.01 as described above.
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on the chip was annotated as Npc1l1. Therefore, expres-
sion of Npc1l1 was investigated by RT-PCR (Table 1).
No significant changes were detected in Npc1l1 expres-
sion in any tissue. Abcg5 and Abcg8, which function as
a heterodimer to efflux cholesterol from the enterocyte
into the gut lumen and from the hepatocyte into bile
[36], showed decreased expression in the liver (Abcg5
p = 2.9 × 10
-7; Abcg8 p = 3.6 × 10
-6) and in the ileum
(Abcg5 p = 0.0062; Abcg8 p = 0.0048) (Table 4).
Transporters
The (ABC) transporters that showed a significant
change in at least one tissue were also investigated
(Table 4). The ABC transporters are a superfamily of
membrane transporters with diverse substrates that in
eukaryotes mediate the ATP-dependent efflux of endo-
genous substrates, including bile acids and cholesterol,
as well as of xenobiotics, including many drugs. The
ABC transporter Abcb1a (Mdr1a) was downregulated in
every tissue. This protein effluxes xenobiotics across the
apical domain of the hepatocyte and enterocyte and
plays an important role in limiting absorption of orally
administered substrates [37]. Two members of the Abcc
(Mrp) subfamily, Abcc5 and Abcc6, were downregulated
in the ileum, while Abcg2 expression was increased in
the duodenum.
Solute carrier proteins (Slcs) are a superfamily of pro-
teins that transport many different molecules, including
amino acids and ions (http://www.bioparadigms.org). All
Slcs on the chip were investigated and those with a
detected significant change in lactation in any tissue are
shown in Additional File 12: Slcs.doc. For each tissue,
nearly 20% of the Slcs showed a change at an overall
physiologic state effect of p < 0.05, and approximately
5% were declared significant after applying a p < 0.01
cutoff within a tissue (simple effect)
Slc39a4 is a transporter mediating the uptake of zinc
in the intestine [38]. Slc39a4_predicted was one of fif-
teen genes to be significantly upregulated in every tissue
(p < 1 × 10
-5) (Additional File 1). Fold changes for
Slc39a4 predicted based on untransformed intensity
values ranged from 1.65 in the jejunum to 2.81 in the
liver (Table 2).
Thyroid signaling
A Fisher’s exact test using IPA detected significant over-
representation in the TR/RXR pathway in every tissue.
(Additional Files 13, 14, 15, 16: Liver_canonical_
pathways.txt, Duodenum_canonical_pathways.txt.,
Jejunum_canonical_pathways.txt., and Ileum_canonical_
pathways.txt). Thyroid hormone receptor a (TRA, Thra)
and thyroid hormone receptor b (TRB, Thrb) were both
downregulated in the ileum and jejunum. A decrease
was also seen in the liver, but the change was not signif-
icant (p = 0.07 for TRA; p = 0.018 for TRB). Surpris-
ingly few of the downstream genes of TR/RXR were
downregulated in the IPA depiction of this pathway. In
some cases, overlap occurred with Srebp signaling, and
increased signaling from Srebp appeared to have over-
ridden decreased thyroid signaling. This seems to have
occurred with Acetyl-CoA Carboxylase alpha (Acaca) in
the liver and Ldlr in both the duodenum and jejunum
[34]. One TRB/RXR regulated gene [39], Kruppel like
factor 9 (Klf9), which is a transcription factor associated
with intestinal proliferation, was downregulated in every
Table 4 ATP-Binding Cassette (ABC) transporters detected to be differentially expressed between Control and
Lactating dams
Gene Symbol
Transcript
Cluster ID RL RD RJ RIL
p < 0.01
Abca3 7065486 0.888
(p = 0.138)
0.931
(p = 0.329)
0.99
(p = 0.874)
0.8
(p = 0.007)
IL
Abca8a_predicted* 7083965 0.567
(p = 7.0E-04)
0.885
(p = 0.273)
0.942
(p = 0.744)
0.763
(p = 0.054)
L
Abcb1a 7250393 0.63
(p = 0.001)
0.663
(p = 0.002)
0.652
(p = 0.002)
0.697
(p = 0.005)
L,D,J,IL
Abcc5 7089622 0.818
(p = 0.021)
1.065
(p = 0.476)
0.938
(p = 0.471)
0.672
(p = 8E-05)
IL
Abcc6 7051110 0.886
(p = 0.109)
0.852
(p = 0.03)
0.884
(p = 0.089)
0.73
(p = 2.0E-04)
IL
Abcg2 7254219 0.949
(p = 0.666)
1.55
(p = 6.0E-05)
1.049
(p = 0.613)
1.203
(p = 0.049)
D
Abcg5 7303106 0.321
(p = 3.0E-07)
0.762
(p = 0.095)
0.901
(p = 0.515)
0.656
(p = 0.006)
L, IL
Abcg8 7294657 0.297
(p = 4.0E-06)
0.67
(p = 0.039)
0.803
(p = 0.261)
0.592
(p = 0.005)
L, IL
The p < 0.01 column indicates in which tissues a change was detected. Abbreviations are as defined for Table 1. *Gene is at the Extended level of confidence.
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pathway.jpg, Duodenum_thyroid_pathway.jpg, Jeju-
num_thyroid_pathway.jpg, and Ileum_thyroid_pathway.
jpg). Klf9 knockout mice have shorter intestinal villi,
although Klf9 is typically considered a transcriptional
repressor and can also negatively regulate growth [40].
Decreased mRNA from T-Cell receptor signaling and
related pathways
mRNA of genes coding for the components of T-Cell
receptor signaling pathway in IPA showed significant
downregulation in the jejunum and ileum (p = 1.68 ×
10
-7 and p = 4.7 × 10
-4, respectively) (Figure 1). A simi-
lar pathway, the “CD28 receptor signaling in T helper
cells” pathway was also downregulated in the jejunum,
but substantial overlap between the two pathways sug-
gested observation of the same events. These pathways
are upstream of IL-2 production [41], however, the
microarray detected no change in IL-2 mRNA in any
tissue.
Discussion
Cholesterol Biosynthesis
IPA and DAVID both flagged “Biosynthesis of Ster-
oids” to be overrepresented in the list of differentially
expressed genes in lactation in three of the four tissues
(the jejunum displayed a p-value near the cutoff), and
the list of genes upregulated in all tissues during lacta-
tion, respectively (Additional Files 7, 8, 9, 10). Visuali-
zation of this pathway revealed that the genes
identified were components of the cholesterol biosyn-
thetic pathway. Statistical pattern matching as well as
results from overrepresentation analyses in both
DAVID and IPA indicated that expression of choles-
terol biosynthetic genes was induced in all tissues
examined, although to a lesser extent in the jejunum
(p = 0.011; Benjamini-Hochberg corrected p = 0.048,
values calculated by IPA). Cholesterol and lipid biosyn-
thetic genes are known to be regulated by transcription
factors known as the Srebp proteins. Three Srebp pro-
teins are encoded by two genes, Srebf1 and Srebf2.
Srebf1 codes for Srebp-1a and Srebp-1c, while Srebf2
codes for Srebp-2. The Srebp proteins differ in their
control of fatty acid synthesis and cholesterol biosynth-
esis [27,42,43]. Srebp-2 is associated with cholesterol
biosynthesis, while the Srebp1 proteins are associated
with fatty acid synthesis [27], although there appears
to be overlap in the genes that are responsive to these
transcription factors [34]. Srebp-1c is sensitive at the
transcriptional level to LXR signaling [42,44,45], while
all three share a mechanism for becoming an active
transcription factor [42]. Under conditions of sufficient
cholesterol concentrations, the protein product of Insu-
lin stimulated gene (Insig) binds to Srebf Chaperone
(Scap) to retain an Insig/Scap/Srebp complex in the
endoplasmic reticulum [42,46]. In the absence of oxy-
sterols and cholesterol, Insig is degraded and Scap is
released from the endoplasmic reticulum; Scap then
escorts the bound Srebp to the Golgi, where the N-
terminus of the Srebp is cleaved from the full protein
to generate the active form that functions as a tran-
scription factor [43]. As indicated above, cholesterol
synthesis is increased during lactation in both the liver
and the small intestine [2,3] and Srebp target genes
have also been shown to be upregulated in mammary
tissue in lactating dams [47].
The observation that Srebp-regulated genes were
upregulated is consistent with early data showing an
overall increased cholesterol biosynthesis in lactation
[5]. We currently do not know which Srebp isoforms
are involved in the changes seen in lactation, as Srebp-
1c, Srebp-1a and Srebp-2, are all able to regulate expres-
sion of cholesterol synthetic genes. However, Srebp-2
plays a stronger role in regulating these genes [27]. The
only potential change detected in the mRNA for a Srebf
gene was Srebf1, the gene associated with Srebp-1a and
Srebp-1c, which showed increased mRNA levels in the
jejunum.
In the liver, Scap mRNA showed a significant
increase (p = 2.2 × 10
-7). If this change were associated
with an increase in Scap protein levels, then a probable
mechanism for the increase in Srebp target genes in
the liver would be increased transport of Srebp pro-
teins to the Golgi, and their subsequent delivery to the
nucleus [42]. Insig1 mRNA also showed a significant
increase in all parts of the small intestine, but not in
the liver. Insig1 functions to retain Srebp in the endo-
plasmic reticulum. Thus, increased expression of Scap
in liver and increased expression of Insig1 in intestine
provide a likely mechanism for the greater increase in
cholesterol synthesis in liver vs. intestine observed by
Feingold et al [5].
A number of factors contribute to the increased need
for cholesterol in the lactating dam. The dam requires
significant cholesterol for the increased synthesis of bile
acids; 50% of cholesterol catabolized in the liver from
nonlactating rats is used for bile acid synthesis [48].
Since the size of bile acid pool increases 2-3-fold at
10-14 d of lactation [15], greater than 50% of cholesterol
is likely catabolized to bile acids in lactation. The pro-
portion of dietary cholesterol vs. endogenously synthe-
sized cholesterol that is catabolized to bile acids in
nonlactating vs. lactating rats is not known. Most
importantly, cholesterol is an essential component of
milk that supports membrane synthesis and neurodeve-
lopment in the pups [49]. About 16 mg per day of cho-
lesterol is secreted into the milk in rats [50]; between 32
and 40% of this cholesterol is synthesized in the
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[7]. Thus, cholesterol synthesized in the liver makes up
about 50% of cholesterol secreted in milk [7].
In addition to detecting a change in cholesterol
synthesis, a possible mechanism for improved net cho-
lesterol uptake was found. Abcg5 and Abcg8 show
decreased levels of mRNA expression in the liver and
ileum. A decrease in the concentration of active
Abcg5/Abcg8 heterodimer in the intestine would be
expected to yield an increase in net cholesterol uptake
through decreased efflux from the enterocyte into the
gut lumen, while decreased hepatic expression would
minimize cholesterol secretion into bile [51]. The
decreased expression of Abcg5/g8 mRNA in the liver,
together with increased expression of cholesterol syn-
thetic genes, likely serve to enhance conservation of
cholesterol to allow for sufficient transfer of choles-
terol into the milk and for synthesis of bile acids.
Increased synthesis of bile acids would in turn serve to
increase cholesterol absorption [16]. Taken together,
these data suggest a concerted mechanism for enhan-
cing net cholesterol absorption and minimizing its
elimination to ensure sufficient cholesterol for incor-
poration into milk and bile acid synthesis, both impor-
tant factors in maintaining the health of both the dam
and pups.
Zinc
Statistical pattern matching found that Slc39a4_
predicted mRNA was increased (1.65 to 2.81 fold) in all
tissues. Slc39a4 is a major zinc transporter associated
with zinc import into the enterocyte [38], and zinc
absorption is up-regulated in lactation [52-55]. Taken
together, these data imply that the increased expression
of Slc39a4 mediates the increased zinc absorption that
occurs in lactation. Zinc is an essential nutrient shown
to be important in bone development [55], to play a
role in stimulating the insulin pathway [56] and in con-
trolling T-Cell activity [57]. Zinc requirements are
increased during lactation relative to pregnancy, and
therefore net zinc uptake needs to be increased to
maintain zinc homeostasis during lactation in humans,
particularly during early lactation [58]. Interestingly,
alpha-2-macroglobulin (A2m) showed a substantial
increase in mRNA expression (~15-fold) in the liver.
Zinc can directly regulate A2m’s ability to sequester
cytokines [57,59,60] by enhancing formation of a form
of A2m that contains free sulfhydryl groups, which serve
as binding sites for the cytokines [60].
Downregulation of mRNA from the T-Cell signaling
pathway
Both the jejunum and ileum showed strong downregula-
tion at the mRNA level of the proteins composing the
T-Cell signaling pathway in IPA. These changes may
reflect a decrease in the number of actual T-Cells in the
small intestine of lactating rats.
Xenobiotic Transporters
Table 4 displays significantly different changes in mRNA
concentration for the ABC transporters. Included in this
list of genes are Abcb1a (Mdr1a), Abcc5, Abcc6, and
Abcg2. Abcb1a showed decreased expression in all tis-
sues in the microarray and this was successfully vali-
dated for the jejunum and ileum by RT-PCR. Abcc5 and
Abcc6 also showed decreased mRNA expression in the
ileum. Decreased expression of these efflux transporters
would in general lead to an increased net absorption of
their substrates. In contrast, Abcg2 showed increased
expression in the duodenum, which would decrease
absorption of substrates. Sample substrates for these
proteins include drugs such as digoxin and cyclosporine
A (Abcb1a, [61]), cGMP (Abcc5 [62]), the glutathione
conjugate leukotriene C4 (Abcc6 [63,64]), and 2-amino-
1-methyl-6-phenylimidazo[4,5-b] pyridine, a dietary
carcinogen (Abcg2 [65]). Further work is needed to
understand the impact of these specific changes within
the context of lactation on the lactating dam and her
pups.
TR/RXR Pathway
IPA found members of the TR/RXR pathway to be over-
represented in the list of differentially expressed genes
in each tissue. In both the ileum and jejunum, both
TRA and TRB showed down-regulation. Although lac-
tating rats are hypothyroid [4] and expressed lower
levels of mRNA for thyroid receptor in these tissues, not
all thyroid responsive genes were down-regulated,
including Apoa5, Eno1, and Glut1, which showed no
change in any tissue. A more detailed picture of the
thyroid receptor pathway can be found in Additional
Files 1718, 19, 20. Serum thyroid hormone levels and
early steps in the pathway are likely downregulated as
an attempt to conserve energy [4,66]. Fisher’se x a c tt e s t
determines its p-values based on the counts of the num-
ber of genes in the list of differentially expressed genes
and compares these to the total number of genes in the
pathway relative to the total number of genes in the
microarray. Therefore, pathways that overlap are likely
to be detected as overrepresented if the overlapping
genes are in the list of differentially expressed genes.
Because some Srebp regulated genes are considered to
be part of the TR/RXR pathway, the p-values for overre-
presentation may be low, even if thyroid signaling over-
all was unchanged. However, changes in the mRNA
levels of the thyroid receptors argue against this, since
these receptors have not been shown to be Srebp
targets.
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The present studies have shown an increase in the
mRNA of enzymes involved in the cholesterol biosynth-
esis pathway, implying that the sterol regulatory element
binding proteins are more active in the liver and small
intestine in lactating vs nonlactating rats. The data are
consistent with a coordinated response to the overall
increased energy demands of lactation and the specific
needs of the pups for cholesterol so that there is ade-
quate cholesterol for incorporation into milk and
increased synthesis of bile acids; the latter in turn func-
tion to increase the intestinal absorption of cholesterol
and lipids. We also demonstrated a marked increase in
the expression of a key transporter important in the
uptake of the essential element, zinc. Finally, we
detected decreased mRNA from genes associated with
T-cell signaling in the jejunum and ileum.
Methods
Animals
Sixteen Sprague-Dawley rats that were lactating for
10-11 days and sixteen age-matched virgin controls were
obtained from Harlan (Indianapolis, IN) and maintained
on a 12 h light/dark cycle (6 AM lights on/6 PM lights
off). Rats had free access to Teklad Global Diet 2018
(Harlan Laboratories, Cincinnati, OH) and water. In
order to minimize the variance in energy demands on the
lactating dam, pups were removed from large litters
within 24 hours of birth so that all litters contained 8-11
pups. All animals were sacrificed at 16 h (10 h of light on
a 12 h light/dark cycle; 4 PM), and the liver, duodenum,
jejunum, and ileum were removed for total RNA extrac-
tion from each tissue. The first 5 cm of the small intes-
tine following the pyloric sphincter was taken as the
duodenum, while the 10 cm following the ligament of
Trietz was discarded and the next 20 cm used as the jeju-
num. The 20 cm segment preceding the cecal valve was
taken as ileum. The mucosal layer was removed by scrap-
ing at 4°C, and used for isolation of RNA from intestinal
segments. RNA was extracted from homogenized tissue
using Trizol (Invitrogen, Carlsbad, CA), and purified
using RNeasy Mini Kit DNAse and columns (Qiagen,
Valencia, CA). The integrity of all RNA samples was veri-
fied using an Agilent 2100 Bioanalyzer (Agilent Technol-
ogies, Santa Clara, CA). Animal protocols were
conducted in accordance with the National Institutes of
Health Guidelines for the Care and Use of Laboratory
Animals and were approved by the Institutional Animal
Care and Use Committee of the University of Kentucky.
Each rat was assigned to one of four pools within the
respective physiologic state (four control pools and four
lactating pools). Pooled RNA samples, consisting of the
RNA from the four rats within the same group, were
created for each tissue, with individual rats composing
the pools consistent across tissues. Each pooled sample
(RNA from one tissue from one set of four rats) was
loaded onto a separate chip. This resulted in the use of
32 chips (4 tissues × 2 “physiologic states” ×4p o o l s ) .
Samples were prepared and processed according to the
manufacturer’s instructions by the University of Ken-
tucky Microarray Core Facility (Lexington, KY).
Selection of Genes on Which to Perform Statistical
Analysis
Affymetrix Expression Console software was used to
perform the Robust Multichip Average (RMA) [67,68]
algorithm, which background corrected, quantile nor-
malized, and log2-transformed gene level summaries of
the Extended dataset. Affymetrix has divided the chip
into various datasets, which represent different confi-
dence levels with respect to the complementarities
between the probe and the sense strand of the gene
sequences. The Extended dataset consists of the Core
dataset, which is made up of Refseq entries and full
length mRNAs, as well as additional multiple annota-
tions based on cDNA libraries. Although the Core data-
set probes are the best annotated, the rat genome is not
as well annotated as the human and mouse genomes,
with many of the genes in the rat Extended dataset
identified based on their similarity to human or mouse
genes. Use of the Extended dataset allowed a more thor-
ough analysis of the genome. The summarized values
are an average taken across all exons.
The exon level Affymetrix DABG (Detection Above
Background) values and the Affymetrix annotation file
(version raex_1_0-st-v1.na27.rn4) were used to filter the
data [69]. Exon level data was opened in Expression
C o n s o l ea n dt h eR M Aa l g o r i t h ma n dl o g 2 transforma-
tions were performed. An exon was considered present
if it had a DABG p < 0.01, indicating that the exon in
question had an intensity greater than 99% of the back-
ground probes with the same GC content [69]. A gene
was considered for analysis if at least one exon was
detected on at least two chips within the same tissue
and the same physiologic state, e.g., presence on two
control liver chips. Genes were also removed if the Affy-
metrix annotation file contained a “—” or a blank for
the “mRNA description” entry (Annotation file:
raex_1_0-st-v1.na27.rn4).O ft h e1 9 , 4 3 4g e n e si nt h e
Extended dataset, 14,129 were utilized for statistical
tests based on these criteria.
Statistical Analysis
Since all four tissues were taken from each rat, a
repeated measures mixed model ANOVA was used to
determine if changes in expression were statistically sig-
nificant for each gene [70]. JMP genomics (SAS Institute
Inc, Cary, NC) was used to perform the ANOVA using
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Tissue, physiologic state, and the tissue*physiologic state
interaction were treated as fixed effects, while “pool”,a
variable describing the combination of four individual
rats to create a sample, was treated as a random subject
variable.
A common method for addressing multiple testing
issues involved in the analysis of microarrays is the
Benjamini-Hochberg false discovery rate (FDR) correc-
tion. Several possibilities existed for attempting to
address the issue of multiple testing. First, the physiolo-
gic state p-value could be adjusted to a fixed FDR.
Alternatively, the individual unadjusted p-values for the
simple effects could be set to a given value and an
approximation of the number of false positives within a
group could then be calculated. We chose the latter
approach, set p < 0.01 as a cutoff and calculated the
proportion of false positives (PFPs) for the simple effects
that represented the pairwise comparisons within a tis-
sue. We chose this method to balance the risk of false
positives with the risk of false negatives. False negatives
i nt h el i s to fd i f f e r e n t i a l l ye x p r e s s e dg e n e sc o u l di n t e r -
fere with downstream pathway analyses.
The overall physiologic state effect of p < 0.05 also
served as an additional cutoff to reduce the total num-
ber of statistical tests performed. Selection of an overall
physiologic state p-value of p < 0.01 was problematic, as
genes that displayed differential expression in only one
tissue might not be noticed due to the lack of change in
the remaining tissues. In summary, genes were consid-
ered differentially expressed between control and lacta-
tion within a tissue if a significant physiologic state
effect was observed at p < 0.05 and a simple effect for
the pairwise comparison within a tissue was p < 0.01.
.CEL files and .CHP files describing the data are avail-
able through GEO under GSE19175 and analyzed data
is available in Additional File 1.
Detection of Biological Trends
Ingenuity Pathways (IPA) (http://www.ingenuity.com)
was used to screen the results for biological trends. Dif-
ferentially expressed genes were determined as described
in the “Statistical Analysis” section above. The Rat Exon
1.0 ST chip was used as a background list.
A right tailed Fisher’s Exact test was used to screen
the IPA database and detect categories that were overre-
presented based on genes detected to have a significant
difference in expression. Available in IPA is the Benja-
mini-Hochberg correction, which attempts to control
the number of false positives. This calculation is depen-
dent on the size of the database. We chose not to use
the Benjamini-Hochberg correction, but chose to fix the
significance threshold at p < 0.01 for any given test. A p
<0 . 0 1f o rt h eF i s h e r ’s Exact test indicated that more
genes in the list of differentially expressed genes
appeared in a pathway than would be expected by
chance if the same number of differentially expressed
genes were to be selected randomly from all genes on
the chip. Both these p-values and the Benjamini-
Hochberg p-values are provided in Table 3.
The lists generated by statistical pattern matching
were analyzed by DAVID [25,29] with the 14,129 genes
used for statistical analyses as the background list.
The lists screened for overrepresentation were the
Canonical Pathways category in IPA and several data-
bases in DAVID (see below). For the Srebp transcription
factors, a report of the differential gene expression in
mice overexpressing isoforms of Srebp and in Scap
knockout mice was used to create an additional list of
genes known to be regulated by the Srebp proteins [34].
Out of the 33 genes listed as regulated by nuclear
Srebp-1a and Srebp2, 29 were identified as being on the
chip at the level of the Extended dataset and were used
to perform a right tailed Fisher’s Exact test.
We used IPA’s Canonical Pathways database for all
changes detected within a tissue, while we used all Gene
Ontology terms, COG ontology, Sp_PIR Keyword
[71,72], UP_SEQ_Feature [71,72], Interpro [73], PIR_Su-
perfamily [74], SMART [75,76], and KEGG [30,77,78] as
databases in DAVID for testing each pattern detected by
statistical pattern matching.
Statistical Pattern Matching
In order to assign changes of RNA expression into bio-
logically meaningful groups, a method of statistical pat-
tern matching was used analogous to the one used by
A r z u a g ae ta l[ 2 3 ]a n dH u l s h i z e ra n dB l a l o c k[ 2 4 ] .
mRNA from any given gene could increase expression,
decrease expression, or show no change in expression in
samples from lactating animals compared to controls in
each tissue. The method for pattern matching is
described in a step by step manner as follows. Only
genes that tested positive for differential expression
were used for pattern matching. These genes were
assigned an additional significance call at p < 0.05 for
each simple effect within a tissue. This was done to pro-
tect against incorrectly assigning a gene that systemati-
cally had low p-values as differentially expressed in only
one tissue. For example, if a gene was downregulated
with p values of less than 0.01 in the liver, duodenum,
and jejunum, and a p of 0.03 in the ileum, the gene was
assigned as differentially expressed in all tissues rather
than in three of the four tissues. Although the gene
would not have been considered differentially expressed
for the purposes of evaluating which genes were differ-
entially expressed in the ileum, the gene was considered
differentially expressed for the purposes of assigning a
pattern. This reduced the risk of falsely assigning the
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tive. The fold-change within a given tissue was then uti-
lized to determine if a gene was upregulated or
downregulated in each tissue. For each tissue, three
values were multiplied to def i n et h ec h a n g ei nt h a tt i s -
sue. One value was an integer that represented the tis-
sue itself: 1000 for liver, 100 for duodenum, 10 for
jejunum, and 1 for ileum. The second value was a multi-
plier to define whether or not there was a tendency (p <
0.05) for the gene to change expression in the given tis-
sue, where p < 0.05 = 1; p > 0.05 = 0). The third value
defined the directionality of the change, where upregula-
tion = 1 and downregulation = - 1. The products of
these values were used to define the change that
occurred within a given tissue. For example a gene upre-
gulated in the liver would have a value of 1000, i.e.,
1000*1*1. The sum of this value for all tissues was taken
to generate a unique value for every set of possible
changes that could occur across tissues. For example a
gene that was upregulated in every tissue except the
ileum, where it was downregulated would have a value
of 1009 (1000 + 100 + 10 - 1). The following groups
were defined to be of particular importance and were
investigated: up in all tissues, down in all tissues, up in
all parts of small intestine, down in all parts of small
intestine, up in liver, down in liver, and down in duode-
num only.
RT-PCR validation of microarray findings
The same total RNA samples used for the microarray
were used for RT-PCR validation; RT-PCR was per-
formed as reported previously [79], using the geometric
average of Ctsb, Tmbim6, and Tmed2 as a normaliza-
tion constant [15]. An aliquot of all cDNA samples was
used to generate a standard curve.
Choosing an appropriate normalization constant was
performed using methodology similar to that described
by Andersen et al [80]. Methods for detecting valid
internal controls require a list of candidate genes with
little or no bias, since any bi a st h a te x i s t sw i t h i nt h e
genes detected as valid internal controls would be trans-
ferred over to the newly calculated normalization factor
[80]. Genes with high expression (mean log2 intensity
from the microarray greater than or equal to 10) were
sorted by their coefficients of variance. Microarray data
for the twenty genes with the lowest coefficients of var-
i a n c ew e r ei n p u ti n t oN o r m f i n d e r[ 8 0 ] .T h es i n g l eb e s t
gene to use as a control was Ctsb, and the best combi-
nation of two was found to be Tmbim6 and Tmed2. We
performed RT-PCR on these genes and chose to use the
geometric mean of the three genes as a normalization
constant. The same statistical model that was used to
analyze the microarray results was used to analyze the
normalized RT-PCR data.
cDNA was synthesized using High-Capacity cDNA
Reverse Transcription Kits from Applied Biosystems
(Foster city, CA) according to the manufacturer’s
instructions. Primers and Universal Probes Library
(UPL) probes for real time RT PCR were designed and
ordered from Roche Applied Science (Mannheim,
Germany) using online software (http://www.universal-
probelibrary.com). A list of primers is provided in Addi-
tional File 21: RT_PCR_primers.doc. The Roche Light
Cycler 480 was used for performing the RT-PCR.
Briefly, 1 μg of total RNA was used for cDNA synthesis,
the synthesized cDNA diluted to 500 μL, and 5 μLo f
diluted cDNA used as template in a 20 μL reaction
volume. For quantification analysis of real time RT-PCR
data, a standard curve was generated by pooling all the
cDNA samples to form one cDNA mixture and then
diluting this cDNA mixture 10-, 100-, 1000- and 10,000-
fold so that expression of the gene of interest was within
the range of the standard curve.
Additional material
Additional File 1: Statistical analysis and statistical pattern
matching results
(Statistical_Analysis_and_Statistical_Pattern_Matching_Results.txt).
Results from statistical pattern matching are reported as a .txt file. Results
are reported for all 14,129 genes considered for statistical analysis, but
genes that were not differentially expressed in any tissue are assigned a
pattern of zero. Transcript_ID is an identifier associated with the gene
analyzed. The gene assignment entry was taken from the Affymetrix
annotation file and displays which gene is associated with the given
transcript ID. Tissue p, physiological state p, and tissue*physiological state
p correspond to the p-values associated with the tissue main effect,
physiological state main effect, and the interaction, respectively. p Liver,
p duodenum, p jejunum, and p ileum represent the p-values associated
with the corresponding simple effects Pattern indicates in which pattern
a gene is detected. A zero indicates no differential expression. Otherwise,
patterns are assigned as described in the Methods. Ratio liver, ratio
duodenum, ratio jejunum, and ratio ileum represent the ratio of the
mean of samples from lactating animals to the mean of samples from
controls utilizing the untransformed microarray data.
Additional File 2: Benjamini-Hochberg false discovery rates
(Benjamini_Hochberg_False_Discovery_Rates.txt). False Discovery
Rate corrections [81] for all genes studied is presented in .txt format.
Transcript_ID is an Affymetrix Identifier for each gene. False discovery
rates are provided for the tissue*physiological state interaction term and
the overall physiological state effect. Q-values were calculated as the
number of false positives expected by chance (uncorrected p* total
number of tests) divided by the total number of results with an equal or
lower p-value.
Additional File 3: Histograms of p-values (Histograms_of_p_values.
ppt). Histograms for A) tissue effect p-values, B) physiological state effect
p-values, C) physiological state*tissue interaction p-values, and pairwise
comparison p-values for D) the liver, E) duodenum, F) jejunum, and G)
ileum presented as a .ppt file. While a large tissue effect was observed, a
visible treatment effect (control vs. lactation) was also observed.
Additional File 4: Volcano plots (Volcano_plots.doc). Volcano plots
comparing the log2 fold changes (reported as mean untransformed
lactating intensity divided by untransformed mean control intensity)
against the calculated pairwise comparison p-value for each individual
tissue in .doc format. Volcano plots are for A) Liver, B) Duodenum, C)
Jejunum, and D) Ileum. Each tissue responded differently to lactation.
The blue line indicates the significance cutoff of p < 0.01. The number of
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duodenum, 402 in the jejunum, and 523 in the ileum, when an overall
treatment main effect p-value cutoff of p < 0.05 was incorporated. Of
particular note is a series of genes that were strongly downregulated in
the duodenum (Additional File 1 pattern -100; discussed in Results.)
Additional File 5: DAVID output (DAVID_output_file.txt). DAVID was
utilized to test specific patterns from statistical pattern matching. Patterns
were chosen based on similarity between tissues and were “Up in All
Tissues”, “Down in all tissues”, “Up in all parts of small intestine”, “Down
in all parts of small intestine”, “Up only in liver”, “Down only in liver”, and
“Down only in duodenum”. Table truncated from output in DAVID.
Genes listed by Affymetrix transcript cluster ID, which may be referenced
in Additional File 1.
Additional File 6: Genes with decreased mRNA in all tissues
(Genes_with_decreased_mrna_all_tissues.doc). To be considered part
of a grouping, genes must have a physiologic state p < 0.05 and at least
one tissue simple effect p < 0.01. Reported p-values are tissue simple
effect p-values and represent the comparison between Lactation and
Control in the corresponding tissue. For the purposes of assigning
patterns, the significance cutoff for the remaining tissue simple effect
was set to p < 0.05. Abbreviations used as in Table 1. *Gene is at the
Extended confidence level.
Additional File 7: Biosynthesis of sterols in liver
(Biosynthesis_of_sterols_in_liver.jpg). Image from IPA representing the
“Biosynthesis of Sterols” in the liver as a .jpg file. Numbering system for
enzymes in the pathway is taken from KEGG [77]. Components of the
cholesterol biosynthetic pathway include 1.1.1.34 (Hmgcr), 2.7.1.36 (Mvk),
2.7.4.2 (Pmvk), 4.1.1.83 (Mvd), 5.3.3.2 (Idi1), 2.5.1.21 (Fdft1), and 1.14.99.7
(Sqle), 5.4.99.7 (Lss), and 1.3.1.21 (Dhcr7). Red shading indicates increased
mRNA during lactation from the corresponding gene.
Additional File 8: Biosynthesis of sterols in duodenum
(Biosynthesis_of_sterols_in_duodenum.jpg). Image from IPA
representing the “Biosynthesis of Sterols” in the duodenum as a .jpg file.
Numbering system for enzymes in the pathway is taken from KEGG [77].
Components of the cholesterol biosynthetic pathway include 1.1.1.34
(Hmgcr), 2.7.1.36 (Mvk), 2.7.4.2 (Pmvk), 4.1.1.83 (Mvd), 5.3.3.2 (Idi1), 2.5.1.21
(Fdft1), and 1.14.99.7 (Sqle), 5.4.99.7 (Lss), and 1.3.1.21 (Dhcr7). Red
shading indicates increased mRNA during lactation from the
corresponding gene.
Additional File 9: Biosynthesis of sterols in jejunum
(Biosynthesis_of_sterols_in_jejunum.jpg). Image from IPA
representing the “Biosynthesis of Sterols” in the jejunum as a .jpg file.
Numbering system for enzymes in the pathway is taken from KEGG [77].
Components of the cholesterol biosynthetic pathway include 1.1.1.34
(Hmgcr), 2.7.1.36 (Mvk), 2.7.4.2 (Pmvk), 4.1.1.83 (Mvd), 5.3.3.2 (Idi1), 2.5.1.21
(Fdft1), and 1.14.99.7 (Sqle), 5.4.99.7 (Lss), and 1.3.1.21 (Dhcr7). Red
shading indicates increased mRNA during lactation from the
corresponding gene.
Additional File 10: Biosynthesis of sterols in ileum
(Biosynthesis_of_sterols_in_ileum.jpg). Image from IPA representing
the “Biosynthesis of Sterols” in the ileum as a .jpg file. Numbering system
for enzymes in the pathway is taken from KEGG [77]. Components of the
cholesterol biosynthetic pathway include 1.1.1.34 (Hmgcr), 2.7.1.36 (Mvk),
2.7.4.2 (Pmvk), 4.1.1.83 (Mvd), 5.3.3.2 (Idi1), 2.5.1.21 (Fdft1), and 1.14.99.7
(Sqle), 5.4.99.7 (Lss), and 1.3.1.21 (Dhcr7). Red shading indicates increased
mRNA during lactation from the corresponding gene.
Additonal File 11: Genes regulated by Srebp proteins
(Genes_Regulated_by_Srebp_proteins.doc). Genes that increase
expression in Srebp-1a overexpressing mice and Srebp-2 overexpressing
mice, and decrease expression in Scap knockout mice [34].
Overrepresentation analysis showed that genes in this list occurred more
frequently than expected by chance in the lists of differentially expressed
genes (p < 1 × 10
-4 in each tissue.) Abbreviations used as in Table 1.
*Gene is at the Extended confidence level.
Additional File 12: Members of the Slc superfamily (Slcs.doc). Table
displaying members of the Slc superfamily. The p < 0.01 column
indicates in which tissues a change was detected. Abbreviations are as
defined for Table 1. * Gene is at the Extended level of confidence.
aSubstrates taken from the SLC tables database (http://www.
bioparadigms.org/)
Additional File 13: Canonical pathways in the liver
(Liver_canonical_pathways.txt). This file contains the canonical
pathways in IPA and the corresponding -log10 p-values and the
individual molecules that were detected as being in the list of
overrepresented genes and part of each pathway (listed in the
“molecules” column.) FDRs for the individual pathways are shown in a
separate series of rows underneath the -log10 p-values. This table shows
results utilizing the list of differentially expressed genes in the liver.
Additional File 14: Canonical pathways in the duodenum
(Duodenum_canonical_pathways.txt). This file contains the canonical
pathways in IPA and the corresponding -log10 p-values and the
individual molecules that were detected as being in the list of
overrepresented genes and part of each pathway (listed in the
“molecules” column.) FDRs for the individual pathways are shown in a
separate series of rows underneath the -log10 p-values. This table shows
results utilizing the list of differentially expressed genes in the
duodenum.
Additional File 15: Canonical pathways in the jejunum
(Jejunum_canonical_pathways.txt). This file contains the canonical
pathways in IPA and the corresponding -log10 p-values and the
individual molecules that were detected as being in the list of
overrepresented genes and part of each pathway (listed in the
“molecules” column.) FDRs for the individual pathways are shown in a
separate series of rows underneath the -log10 p-values. This table shows
results utilizing the list of differentially expressed genes in the jejunum.
Additional File 16: Canonical pathways in the ileum
(Ileum_canonical_pathways.txt). This file contains the canonical
pathways in IPA and the corresponding -log10 p-values and the
individual molecules that were detected as being in the list of
overrepresented genes and part of each pathway (listed in the
“molecules” column.) FDRs for the individual pathways are shown in a
separate series of rows underneath the -log10 p-values. This table shows
results utilizing the list of differentially expressed genes in the ileum.
Additional File 17: Thyroid pathway in liver (Liver_thyroid_pathway.
jpg). Images from IPA for the TR/RXR pathway for the liver. Red shading
indicates increased mRNA amounts of the respective gene during
lactation, and green shading indicates decreased amounts of mRNA.
Additional File 18: Thyroid pathway in duodenum
(Duodenum_thyroid_pathway.jpg). Images from IPA for the TR/RXR
pathway for the duodenum. Red shading indicates increased mRNA
amounts of the respective gene during lactation, and green shading
indicates decreased amounts of mRNA.
Additional File 19: Thyroid pathway in jejunum
(Jejunum_thyroid_pathway.jpg). Images from IPA for the TR/RXR
pathway for the jejunum. Red shading indicates increased mRNA
amounts of the respective gene during lactation, and green shading
indicates decreased amounts of mRNA.
Additional File 20: Thyroid pathway in ileum
(Ileum_thyroid_pathway.jpg). Images from IPA for the TR/RXR pathway
for the ileum. Red shading indicates increased mRNA amounts of the
respective gene during lactation, and green shading indicates decreased
amounts of mRNA.
Additional File 21: RT-PCR primers (RT_PCR_primers.doc). Primer
sequences for all genes analyzed by RT-PCR.
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